Hepatic steatosis, a hallmark of MASLD, increases the secretion of pro-oncogenic hepatokines such as fetuin-A and angiopoietin-like protein 8 (ANGPTL8), often in complex with ANGPTL3 or ANGPTL4 [159,160]. This evidence concerns the gene ANGPTL8 and metabolic dysfunction-associated steatotic liver disease.